Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: J Subst Use Addict Treat. 2023 Dec 14;158:209261. doi: 10.1016/j.josat.2023.209261

Table A.2.

Bup Rx at Follow-up Visits Among Patients with OUD versus Chronic Pain Only, N = 28

Bupe rx at follow up n=16 No bupe rx at follow up n=12 p-value Bupe rx 30 days n=14 No bupe rx 30 days n=14 p-value Bupe rx 90 days n=13 No bupe rx 90 days n=15 p-value
OUD* 10 (62.5) 12 (100) 0.02 8 (57.1) 14 (100) 0.02 8 (61.5) 14 (93.3) 0.07

OUD, opioid use disorder;

*

reference group = patient with chronic pain only